Actively Recruiting
Registry Study of Patients with Neonatal-Onset Epileptic Encephalopathy to Understand Clinical and Developmental Features
Led by Assistance Publique Hopitaux De Marseille · Updated on 2025-11-20
200
Participants Needed
15
Research Sites
156 weeks
Total Duration
AI-Summary
What This Trial Is About
Epileptic encephalopathies starting in the first months of life are rare, severe conditions associated with rapid loss of motor, cognitive, and behavioral skills. This research focuses on a specific genetic form called KCNQ2-related epileptic encephalopathy KCNQ2-REE, caused by mutations in the KCNQ2 gene affecting brain excitability. Patients typically experience early-onset seizures with a distinctive EEG pattern and severe developmental challenges despite some seizure remission. The study involves creating a register of patients with neonatal-onset epileptic encephalopathy linked to KCNQ2 mutations. Data collection includes detailed clinical descriptions, EEG, imaging, developmental progress, and long-term follow-up characteristics. The main intervention is a survey using a structured questionnaire conducted through face-to-face interviews with parents or guardians. Participants and their families will provide information over time to help define the developmental disorder and epilepsy phases by 36 months of age. The study aims to better understand the clinical and molecular features, progression, and potential treatment approaches for this condition. The research involves ongoing observation without altering standard care, with data gathered primarily through interviews and medical evaluations.
CONDITIONS
Brief Title
Creation of a Register of Patients With Neonatal-onset Epileptic Encephalopathy
Research Team
M
Mathieu Milh
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here